FDA Inspection 1106973 — Ming-Shen Dai, M.D., Ph.D.
The FDA completed an inspection of Ming-Shen Dai, M.D., Ph.D. on September 27, 2019 in Taipei City. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 27, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Taipei City (Taiwan)
Additional Details
Clinical Investigator (CI)